These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30685104)

  • 41. Reference intervals and decision limits for B-type natriuretic peptide (BNP) and its precursor (Nt-proBNP) in the elderly.
    Alehagen U; Goetze JP; Dahlström U
    Clin Chim Acta; 2007 Jul; 382(1-2):8-14. PubMed ID: 17433809
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biochemistry of B-type natriuretic peptide--where are we now?
    Mair J
    Clin Chem Lab Med; 2008; 46(11):1507-14. PubMed ID: 18842106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation of natriuretic peptides and inferior vena cava size in patients with congestive heart failure.
    Hebl V; Zakharova MY; Canoniero M; Duprez D; Garcia S
    Vasc Health Risk Manag; 2012; 8():213-8. PubMed ID: 22536076
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical evaluation of capillary B-type natriuretic peptide testing.
    Schreinlechner M; Mrakovic A; Laschober G; Mayerl C; Griesmacher A; van Lippen L; Semjonow V; Nieuwenhuis J; van Reenen A; Mair J
    Clin Chem Lab Med; 2020 Mar; 58(4):618-624. PubMed ID: 31804953
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Direct comparison of transcardiac increase in brain natriuretic peptide (BNP) and N-terminal proBNP and prognosis in patients with chronic heart failure.
    Tsutamoto T; Sakai H; Nishiyama K; Tanaka T; Fujii M; Yamamoto T; Horie M
    Circ J; 2007 Dec; 71(12):1873-8. PubMed ID: 18037739
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictors of increased cumulative serum levels of the N-terminal prohormone of brain natriuretic peptide 4 days after acute spontaneous subarachnoid hemorrhage.
    Nyberg C; Karlsson T; Ronne-Engström E
    J Neurosurg; 2014 Mar; 120(3):599-604. PubMed ID: 24093631
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide: biomarkers for mortality in a large community-based cohort free of heart failure.
    McKie PM; Rodeheffer RJ; Cataliotti A; Martin FL; Urban LH; Mahoney DW; Jacobsen SJ; Redfield MM; Burnett JC
    Hypertension; 2006 May; 47(5):874-80. PubMed ID: 16585413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP).
    Chenevier-Gobeaux C; Claessens YE; Voyer S; Desmoulins D; Ekindjian OG
    Clin Chim Acta; 2005 Nov; 361(1-2):167-75. PubMed ID: 15993397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of brain natriuretic peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure.
    Emdin M; Passino C; Prontera C; Fontana M; Poletti R; Gabutti A; Mammini C; Giannoni A; Zyw L; Zucchelli G; Clerico A
    Clin Chem; 2007 Jul; 53(7):1289-97. PubMed ID: 17495021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. B-type natriuretic peptide over N-terminal pro-brain natriuretic peptide to predict incident atrial fibrillation after cryptogenic stroke.
    Palà E; Pagola J; Juega J; Francisco-Pascual J; Bustamante A; Penalba A; Comas I; Rodriguez M; De Lera Alfonso M; Arenillas JF; de Torres R; Pérez-Sánchez S; Cabezas JA; Moniche F; González-Alujas T; Molina CA; Montaner J
    Eur J Neurol; 2021 Feb; 28(2):540-547. PubMed ID: 33043545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of renal dysfunction on BNP, NT-proBNP, and their ratio.
    Srisawasdi P; Vanavanan S; Charoenpanichkit C; Kroll MH
    Am J Clin Pathol; 2010 Jan; 133(1):14-23. PubMed ID: 20023254
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
    Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
    [TBL] [Abstract][Full Text] [Related]  

  • 55. B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.
    Bal L; Thierry S; Brocas E; Van de Louw A; Pottecher J; Hours S; Moreau MH; Perrin Gachadoat D; Tenaillon A
    Acta Anaesthesiol Scand; 2006 Mar; 50(3):340-7. PubMed ID: 16480468
    [TBL] [Abstract][Full Text] [Related]  

  • 56. N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease.
    Bibbins-Domingo K; Gupta R; Na B; Wu AH; Schiller NB; Whooley MA
    JAMA; 2007 Jan; 297(2):169-76. PubMed ID: 17213400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients.
    O'Hanlon R; O'Shea P; Ledwidge M; O'Loughlin C; Lange S; Conlon C; Phelan D; Cunningham S; McDonald K
    J Card Fail; 2007 Feb; 13(1):50-5. PubMed ID: 17339003
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testing for BNP and NT-proBNP in the diagnosis and prognosis of heart failure.
    Balion C; Santaguida PL; Hill S; Worster A; McQueen M; Oremus M; McKelvie R; Booker L; Fagbemi J; Reichert S; Raina P
    Evid Rep Technol Assess (Full Rep); 2006 Sep; (142):1-147. PubMed ID: 17764210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.